A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...

NSCLC is diagnosed at an advanced stage in nearly 50% of patients and often has a poor prognosis with worsening outcomes after each line of subsequent therapy. 1,2,3 While first-line treatment ...

Current AI models struggle to solve research-level math problems, with the most advanced AI systems we have today solving just 2% of the hundreds of challenges faced.